IHR Participates in Nation-wide Study on Pregnancy and COVID-19
In order to help promote the care and safety of our pregnant patients and their babies during the COVID-19 pandemic, IHR has partnered up with other clinics across the U.S. in the ASPIRE Study. So far 79 clinics/networks strong across 27 states, and 275 patients have already enrolled.
Are you interested in signing up?
All pregnant patients are eligible to participate. We encourage you to consider it and are here to answer any questions you may have. During this unprecedented time, we know there can be more questions than answers. This study is an important step in providing better fertility care under new global conditions.
To participate or learn more, please visit aspire.ucsf.edu
Alternatively, please email email@example.com with your contact information. A study coordinator will be in touch regarding enrolling in the ASPIRE study.
Aspire in the News
Watch an interview with ASPIRE investigator Dr. Huddleston and an impressive participant about the study (on ABC).
Check out ASPIRE’s FAQ page for prospective patients - https://aspire.ucsf.edu/interested-participants